InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Passage BIO, Inc.

PASG Clue Score25
United States Fiscal year ends December CIK 0001787297 Results filed 3 Mar 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Kathleen Borthwick
8 Jan 2026
CFO
Sold after exercise
2,062
$18.44
$38.02K
William Chou
8 Jan 2026
President and CEO
Sold after exercise
4,076
$18.44
$75.16K
Simona King
28 Jul 2023
Chief Financial Officer
Sold after exercise
11,453
$0.88
$10.08K
Simona King
18 Apr 2023
Chief Financial Officer
Sold after exercise
2,053
$1.05
$2.16K
Alexandros Fotopoulos
22 Nov 2022
Chief Technical Officer
Sold after exercise
3,720
$1.33
$4.95K
Gary Romano
15 Mar 2021
Chief Medical Officer
Sold after exercise
1,617
$21.86
$35.35K
Gary Romano
15 Mar 2021
Chief Medical Officer
Sold after exercise
8,383
$20.95
$175.66K
Show all 86 transactions →

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 23
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 24,273,474
Sales filed before the plan box existed 4
History held since 2 Mar 2020